Parker-Hannifin Beats Q1, Lifts FY27 EPS Guidance to $36.45-$37.25
PH sits 20% above its 52-week low of $755.1.
Summary
Parker-Hannifin beat fiscal Q1 on both lines: adjusted EPS of $8.90 versus the $8.19 consensus and sales of $5.992 billion versus $5.735 billion expected. Sales rose 18% with 11.5% organic growth, and adjusted segment operating margin hit a record 28.6%, up 120 basis points. The bigger news is guidance: management raised fiscal 2027 adjusted EPS to $36.45-$37.25 from $34.25-$35.25, above the $35.55 consensus, and lifted sales guidance to $24.939 billion-$25.584 billion from $22.681 billion-$23.326 billion. GAAP EPS guidance was cut to $29.65-$30.45 from $30.00-$31.00, reflecting the Filtration Group deal's purchase accounting, so the adjusted-versus-GAAP gap is worth noting. Filtration Group, closed per the August 10-K, is expected to contribute about $1.85 billion of fiscal 2027 sales with a target of more than 30% adjusted EBITDA margin by fiscal 2030 backed by $220 million of cumulative cost synergies. Record backlog of $13.7 billion and rolling 12-month orders up 13% support the higher organic growth guide of 7.5%-10.5%.
At the time of this announcement, PH was trading at $904.01 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $114B. The 52-week trading range was $755.10 to $1,099.94. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Benzinga.